These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 10618274)

  • 1. Antibody responses to antigenic sites 1 and 3 of serotype 3 poliovirus after vaccination with oral live attenuated or inactivated poliovirus vaccine and after natural exposure.
    Herremans T; Reimerink JH; Kimman TG; van Der Avoort HG; Koopmans MP
    Clin Diagn Lab Immunol; 2000 Jan; 7(1):40-4. PubMed ID: 10618274
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nasopharyngeal secretory antibody response to poliovirus type 3 virion proteins exhibit different specificities after immunization with live or inactivated poliovirus vaccines.
    Zhaori G; Sun M; Faden HS; Ogra PL
    J Infect Dis; 1989 Jun; 159(6):1018-24. PubMed ID: 2470831
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunogenicity of a supplemental dose of oral versus inactivated poliovirus vaccine.
    Moriniere BJ; van Loon FP; Rhodes PH; Klein-Zabban ML; Frank-Senat B; Herrington JE; Pallansch MA; Patriarca PA
    Lancet; 1993 Jun; 341(8860):1545-50. PubMed ID: 8099637
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative evaluation of immunization with live attenuated and inactivated poliovirus vaccines.
    Ogra PL
    Ann N Y Acad Sci; 1995 May; 754():97-107. PubMed ID: 7625685
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of a poliovirus-binding inhibition assay as an alternative to the virus neutralization test.
    Herremans MM; Reimerink JH; Ras A; Van Der Avoort HG; Kimman TG; Van Loon AM; Conyn-Van Spaendonck MA; Koopmans MP
    Clin Diagn Lab Immunol; 1997 Nov; 4(6):659-64. PubMed ID: 9384285
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Induction of mucosal immunity by inactivated poliovirus vaccine is dependent on previous mucosal contact with live virus.
    Herremans TM; Reimerink JH; Buisman AM; Kimman TG; Koopmans MP
    J Immunol; 1999 Apr; 162(8):5011-8. PubMed ID: 10202050
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative evaluation of immunization with live attenuated and enhanced-potency inactivated trivalent poliovirus vaccines in childhood: systemic and local immune responses.
    Faden H; Modlin JF; Thoms ML; McBean AM; Ferdon MB; Ogra PL
    J Infect Dis; 1990 Dec; 162(6):1291-7. PubMed ID: 2172403
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intestinal trypsin can significantly modify antigenic properties of polioviruses: implications for the use of inactivated poliovirus vaccine.
    Roivainen M; Hovi T
    J Virol; 1987 Dec; 61(12):3749-53. PubMed ID: 2824812
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Primary and booster vaccination with an inactivated poliovirus vaccine (IPV) is immunogenic and well-tolerated in infants and toddlers in China.
    Li R; Li CG; Li Y; Liu Y; Zhao H; Chen X; Kuriyakose S; Van Der Meeren O; Hardt K; Hezareh M; Roy-Ghanta S
    Vaccine; 2016 Mar; 34(12):1436-43. PubMed ID: 26873055
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The response to oral poliovaccine in persons aged 16-18 years.
    Smith JW; Lee JA; Fletcher WB; Morris CA; Parker DA; Yetts R; Magrathe DI; Perkins FT
    J Hyg (Lond); 1976 Apr; 76(2):235-47. PubMed ID: 177700
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Poliovirus-specific immunoglobulin A in persons vaccinated with inactivated poliovirus vaccine in The Netherlands.
    Herremans MM; van Loon AM; Reimerink JH; Rümke HC; van der Avoort HG; Kimman TG; Koopmans MP
    Clin Diagn Lab Immunol; 1997 Sep; 4(5):499-503. PubMed ID: 9302194
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sequential inactivated (IPV) and live oral (OPV) poliovirus vaccines for preventing poliomyelitis.
    Ciapponi A; Bardach A; Rey Ares L; Glujovsky D; Cafferata ML; Cesaroni S; Bhatti A
    Cochrane Database Syst Rev; 2019 Dec; 12(12):CD011260. PubMed ID: 31801180
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Surveillance of immunity acquired from poliovirus immunization including vaccination with the Sabin strain-derived inactivated vaccine.
    Hotta C; Ogawa T; Shirasawa H
    Hum Vaccin Immunother; 2019; 15(5):1154-1159. PubMed ID: 30676843
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The safety and immunogenicity of two novel live attenuated monovalent (serotype 2) oral poliovirus vaccines in healthy adults: a double-blind, single-centre phase 1 study.
    Van Damme P; De Coster I; Bandyopadhyay AS; Revets H; Withanage K; De Smedt P; Suykens L; Oberste MS; Weldon WC; Costa-Clemens SA; Clemens R; Modlin J; Weiner AJ; Macadam AJ; Andino R; Kew OM; Konopka-Anstadt JL; Burns CC; Konz J; Wahid R; Gast C
    Lancet; 2019 Jul; 394(10193):148-158. PubMed ID: 31174831
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characteristics of the immune response to poliovirus virion polypeptides after immunization with live or inactivated polio vaccines.
    Zhaori G; Sun M; Ogra PL
    J Infect Dis; 1988 Jul; 158(1):160-5. PubMed ID: 2839578
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differences in Antigenic Structure of Inactivated Polio Vaccines Made From Sabin Live-Attenuated and Wild-Type Poliovirus Strains: Impact on Vaccine Potency Assays.
    Crawt L; Atkinson E; Tedcastle A; Pegg E; ; Minor P; Cooper G; Rigsby P; Martin J
    J Infect Dis; 2020 Feb; 221(4):544-552. PubMed ID: 30788503
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunogenicity and reactogenicity of rhesus rotavirus vaccine given in combination with oral or inactivated poliovirus vaccines and diphtheria-tetanus-pertussis vaccine.
    Jalil F; Zaman S; Carlsson B; Glass RI; Kapikian AZ; Mellander L; Hanson LA
    Trans R Soc Trop Med Hyg; 1991; 85(2):292-6. PubMed ID: 1653474
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Global eradication of poliomyelitis: reinvent the wheel or use existing options effectively?
    Ogra PL
    Public Health Rev; 1993-1994; 21(1-2):143-50. PubMed ID: 8041881
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anomalous observations on IPV and OPV vaccination.
    John TJ
    Dev Biol (Basel); 2001; 105():197-208. PubMed ID: 11763328
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A comparative study of reactogenicity and immunogenicity of an oral and an inactivated polio vaccine.
    Borcić B; Dobrovsak-Sourek V; Kaić B; Ljubicić M
    Acta Med Croatica; 1998; 52(3):155-8. PubMed ID: 9818437
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.